跳至主要内容
临床试验/IRCT20181015041353N1
IRCT20181015041353N1招募中3 期

Study of the effectiveness of Tiotropium bromide in patients with severe asthma

Zahedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with severe asthma who have been treated with routine anti-asthma drugs
  • Being under treatment with routine anti-asthma drugs
  • Labeled as grade 4 or 5 of asthma
  • Age of 18 years and more

排除标准

  • lactation (Breastfeeding)
  • Using hormonal contraceptives drugs
  • High pregnancy probability
  • Chronic obstructive pulmonary disease (COPD)
  • Having other pulmonary diseases
  • Infection of the respiratory system
  • Audio cord performance dysfunction
  • smokers with more than 10 pack per year
  • History of taking muscarinic anticholinergic drugs
  • History of taking other anticholinergic drugs
  • Inability to use the drugs prescribed in this study

研究者

发起方
Zahedan University of Medical Sciences

相似试验

招募中
3 期
Evaluation of therapeutic effect of Tiotropium Bromide in early stages of chronic obstructive pulmonary disease in patients of subspecialty clinics of Isfahan university of medical science in 2018 - 201
IRCT20190524043684N1Esfahan University of Medical Sciences92
已完成
不适用
Efficacy of Tiotropium bromide (Spiriva 2.5 microgram Respimat 60 puffs) for chronic asthmatic cough refractory to intensive therapiesasthma
JPRN-UMIN000021064agoya City University Dept of Respiratory Medicine, Allergy and Clinical Immunology58
进行中(未招募)
不适用
Influence of tiotropium bromide (Spiriva ®) plus salbutamol versus salbutamol on the mucin secretion and sputum properties in subjects with a COPD exacerbation-TIBROMUC- - TIBROMUCAnticholinergic bronchodilators, such as ipratropium bromide, may be used in combination with beta adrenergic agonists as SAlbutamol to produce bronchodilation in excess of that achieved by either agent alone.Therefore we will treat both study arms with salbutamol. One group A will receive tiotropium bromide with salbutamol, while the other group B will receive salbutamol.MedDRA version: 8.1Level: LLTClassification code 10010952Term: COPD
EUCTR2006-005819-10-DEPhilipps-University Marburg
已完成
4 期
Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During ExerciseCOPD
NCT00412204McMaster University20
已完成
不适用
Efficacy of Tiotropium Bromide Hydrate on human bronchial mucocillially movement using bronchoscopic specimeRespiratory disease requiring bronchoscopy
JPRN-UMIN000011351Respiratory medicine and oncology Gifu Municipal Hospital50
The effectiveness of Tiotropium bromide in patients... | 临床试验